MorphoSys AG secured a profit of €16.9 million in the first nine months of 2013 compared with a year-earlier loss of €1.2 million on revenue of €63.6 million, up by 80% from a year earlier – the result of two transformative deals announced in June. ---Subscribe to MedNous to access this article--- Company News
